Skip to Primary Navigation

Skip to main content

Report to US lawmakers flags impact of China pharma on US drug supply chain

CHONGQING, CHINA - OCTOBER 7: A woman walks past rows of Chinese national flags displayed at the square in front of the Chongqing People's Auditorium during the National Day Golden Week holiday on October 7, 2025, in Chongqing, China. Streets and public squares across the country are decorated with national flags to celebrate the founding of the People's Republic of China.
Photo: Cheng Xin/Getty Images

Kevin Kinsella

2 min read

The report urges Congress to bolster US pharmaceutical supply-chain resilience and reduce dependence on China.

supply chain. According
, , , , , , ,

Get full access, free for a month

Start your 28-day free trial to continue reading and access all content on GRIP – no payment details required.

Start free trial
Sign in

What’s included:

  • Every new article, plus our 5,000+ archive
  • Daily regulatory insight and guidance
  • Exclusive interviews and in-depth analysis
  • Coverage of industry-leading events and conferences
  • All podcasts and videos, featuring industry experts
  • The full set of Rules Navigator tools
  • An ad-free experience